Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Anticancer Research|July 1, 1997
Prognostic value of TP53 protein accumulation in human primary breast cancer: an analysis by luminometric immunoassay on 1491 tumor cytosolsE M Berns, H H De Witte, J G Klijn, et al.
Clinical Endocrinology|June 1, 1988
Heterozygotes for 17 alpha-hydroxylase deficiency can be detected with a short ACTH testJ M Wit, H P van Roermund, W Oostdijk, et al.
The Veterinary Quarterly|January 1, 1989
Application of diethylstilbestrol dipropionate in bulls. I. Excretion of residues in urine and faeces and histological and immunohistochemical changes in the prostateE H Jansen, R W Stephany, J G Vos, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): report of an EORTC/BIOMED-1 workshopT J Benraad, J Geurts-Moespot, J Grøndahl-Hansen, et al.
Endocrinology|March 1, 1992
Chronic stimulation of the pituitary-adrenal axis in rats by interleukin-1 beta infusion: in vivo and in vitro studiesC G Sweep, M J van der Meer, A R Hermus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancerE M Berns, J G Klijn, W L van Putten, et al.
British Journal of Cancer|July 2, 1999
Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancerJ H de Witte, C G Sweep, J G Klijn, et al.
British Journal of Cancer|March 31, 1999
Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patientsJ H de Witte, C G Sweep, J G Klijn, et al.
British Journal of Cancer|December 4, 1998
External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extractsC G Sweep, J Geurts-Moespot, N Grebenschikov, et al.
Pageof 13